Instrument Business Outlook Volume 31 - Issue 11
-
Danaher Makes a Big Move
-
Life Sciences
-
Diagnostics
-
EAS
-
Commentary
-
New Labs in Various End-Markets
-
Samsung Commits Over $700 Million
-
Major Public Health Lab Announced
-
NCI-Designated Cancer Center to Expand
-
Dedicated Cancer Research Center Starts Construction
-
New German Lab Will Conduct Materials Research
-
Executive Briefing
-
Danaher Set to Spin Off Environmental & Applied Solutions Business
-
EU Rules Against Illumina-GRAIL Deal
-
MGI Tech Completes IPO
-
OpenEye Fetches $500 Million
-
Beckman Coulter Life Sciences Further Invests in Manufacturing Testing Solutions
-
Park Systems Makes First Acquisition
-
SFC Supplier Sold
-
Second Quarter Results: Bio-Techne, Biotage, Pacific Biosciences, Shimadzu and Tecan
-
Bio-Techne Finishes Fiscal 2022 With Strength
-
Biotage Posts Solid Revenue Growth in the Americas and China
-
Pacific Biosciences Faces Challenges in the Second Quarter
-
Shimadzu AMI’s Academia/Government End-Market Revenue a Sales Leader
-
Tecan Post Broad-Based Strength Across Product Lines and Regions
-
Market Profile: Eddy Current Testing
-
Leading Vendors
-
Largest Markets
-
Instrument Cost
-
Industry Watch
-
Semiconductor
-
Energy
-
Clinical
-
Region Watch
-
News
-
Broad-Based Companies
-
Company Announcements
-
Sales & Orders of Note
-
Life Science Instruments
-
Company Announcements
-
Product Introductions
-
Gene-Based Analysis
-
Company Announcements
-
Product Introductions
-
Sales/Orders of Note
-
Cell-Based Analysis
-
Company Announcements
-
Product Introductions
-
Sales & Orders of Note
-
Protein-Based Analysis
-
Company Announcements
-
Product Introductions
-
Sales & Orders of Note
-
Sequencing
-
Company Announcements
-
Product Introductions
-
Sales & Orders of Note
-
Laboratory Products
-
Consumables
-
New Products
-
Laboratory Automation
-
Company Announcements
-
Product Introductions
-
Laboratory Equipment
-
Company Announcements
-
Product Introductions
-
Bottom Line